Hybridoma research and development is a powerful method and key path for the generation of antibody drugs. CD BioSciences has established an antibody drug discovery platform based on many years of customized antibody production experience and excellent antibody drug R&D team. CD BioSciences' hybridoma R&D services can use a variety of immune methods, high-throughput joint screening and a series of functional tests. CD BioSciences can provide dozens of high-quality functional hybridoma clones to ensure that your antibody drug development road has a successful start.
✓ CD BioSciences' in vivo discovery immune team provides high-performance hybridoma-based technology that can help customers discover outstanding antibodies that can work.
✓ CD BioSciences provides a variety of immune programs (DNA, protein, peptide, small molecule and cell-based immune programs), and has adopted a variety of advanced tolerance destruction methods to produce fully human in a variety of wild-type murine strains. It will take time to prove that the source antibody transgenic mice are successful.
✓ CD BioSciences targets a variety of therapeutic and clinical diagnostic/imaging candidates for immuno-oncology targets, GPCRs, neurobiological targets, enzymes, autoimmune/inflammatory targets, metabolic targets and small molecules.
✓ CD BioSciences' high-throughput screening based on ELISA and FACS and the failure rate analysis of hybridoma cells showed that the specificity, cross-reactivity and functionality of the candidate antibody can be as early as two months after the start of the event.
✓ CD BioSciences specializes in hybridoma services and we are committed to contributing to more customers.
✓ CD BioSciences has in-depth cooperation with many pharmaceutical companies and research institutes, and has extensive experience in providing them with high-quality products and services.
✓ CD BioSciences provides all services related to hybridoma services in a flexible and comprehensive manner.
Our Service Items
|Project name||Hybridoma services|
CD BioSciences offers hybridoma service to meet the specific needs of different customers.
✓ Comprehensive immunization methods: Various antigen immunization programs such as protein, peptide, whole cell and DNA can be provided.
✓ One-stop service: Provide all services from antigen production to hybridoma research and development and identification.
✓ High-throughput screening: high screening efficiency.
✓ Comprehensive functional testing services: The functional verification testing platform provides reliable in vitro pharmacodynamic testing services such as epitope identification.
✓ A variety of downstream services are seamlessly connected: antibody sequencing, antibody humanization, large-scale antibody production, and anti-idiotypic antibodies and other downstream services to help you study the PD/PK functions of antibody drugs.
|Product delivery mode||
We will complete the project on time according to the agreed time.
Why choose us?
CD BioSciences provides professional hybridoma services service to meet the needs of regular customers to determine hits on time and on budget. CD BioSciences relies on the world-class technical expertise, we provide customers with the best quality hybridoma services, including the development of experimental procedures according to different experimental needs. Please feel free to contact us for more detailed information, our scientists will tailor the most reasonable plan for your project.